← Back to Search

CAR T-cell Therapy

A for HIV/AIDS

Phase 2

Waitlist Available

Research Sponsored by VIRxSYS Corporation

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 15 years

Awards & highlights

Study Summary

This trial is testing a new treatment for HIV using the patient's own cells. Infusions of modified cells are given every other week, and the study will enroll up to 40 people.

Eligible Conditions

HIV/AIDS

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 15 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~15 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in CD4 counts

Change in viral load

Safety

Secondary outcome measures

AIDS related illness

Immune function

Persistence of vector modified cells

Trial Design

1Treatment groups

Experimental Treatment

Group I: AExperimental Treatment1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

VIRxSYS CorporationLead Sponsor

1 Previous Clinical Trials

40 Total Patients Enrolled

Tessio Rebello, PhDStudy DirectorVIRxSYS Corporation

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities to join this research project at the moment?

"Per the records available on clinicaltrials.gov, this particular medical trial is no longer seeking participants since it was last updated in 2011. Fortunately, 635 other trials are actively enrolling patients at this time."

Answered by AI

How many medical centers are administering the trial in this urban area?

"The clinical trial is offering its services at CIRCLE Medical, LLC in Norwalk, Connecticut; Stanford AIDS Clinical Trials Unit in Palo Alto, California; University of Kentucky in Lexington, Kentucky and five other medical centres."

Answered by AI

What demographics qualify for enrollment in this research project?

"This clinical trial is recruiting 60 participants aged between 18 and 65 that are living with HIV. To be eligible, potential candidates must comply with the following conditions: if on antiretroviral therapy, they must remain so; otherwise, a wash-out period of 6 weeks prior to screening is required; those not already receiving treatment must abstain from such for up to one year throughout the study's duration. Moreover, enrollees need to fulfill other criteria including being male or female, having a Karnofsky Performance score higher than 80 out of 100 and over 50 Kg in body weight as well as adequate venous access without any cont"

Answered by AI

What risks do individuals face when undergoing this particular course of treatment?

"With a score of 2, our team at Power has determined that this treatment is likely secure based on the fact it's in its second phase of trials and data supporting safety, though not efficacy."

Answered by AI